AEDNX
Price
$13.36
Change
-$0.02 (-0.15%)
Updated
Jul 31 closing price
Net Assets
51.23M
WCERX
Price
$10.27
Change
+$0.02 (+0.20%)
Updated
Jul 31 closing price
Net Assets
131.4M
Interact to see
Advertisement

AEDNX vs WCERX

AEDNX vs WCERX Comparison Chart in %
View a ticker or compare two or three
VS
AEDNX vs. WCERX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEDNX is a Hold and WCERX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
WCERX has more cash in the bank: 131M vs. AEDNX (51.2M). WCERX pays higher dividends than AEDNX: WCERX (5.77) vs AEDNX (0.91). AEDNX was incepted earlier than WCERX: AEDNX (16 years) vs WCERX (9 years). WCERX (2.12) is less costly to investors than AEDNX (1.62). WCERX is a more actively managed with annual turnover of: 255.00 vs. AEDNX (195.00). WCERX has a lower initial minimum investment than AEDNX: WCERX (2500) vs AEDNX (100000). AEDNX annual gain was more profitable for investors over the last year : 7.46 vs. WCERX (-1.79). AEDNX return over 5 years is better than : 23.18 vs. WCERX (4.08).
AEDNXWCERXAEDNX / WCERX
Total Expense Ratio1.461.9176%
Annual Report Gross Expense Ratio1.622.1276%
Fund Existence16 years9 years-
Gain YTD4.3751.382317%
Front LoadN/A6%-
Min. Initial Investment10000025004,000%
Min. Initial Investment IRAN/AN/A-
Net Assets51.2M131M39%
Annual Yield % from dividends0.915.7716%
Returns for 1 year7.46-1.79-417%
Returns for 3 years21.539.36230%
Returns for 5 years23.184.08568%
Returns for 10 years54.42N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAFCX33.600.61
+1.85%
American Funds AMCAP 529-C
LMVRX134.580.30
+0.22%
ClearBridge Value R
FLMIX11.27-0.01
-0.09%
Meeder Muirfield Institutional
TRMSX24.22-0.11
-0.45%
T. Rowe Price Mid-Cap Index I
CRRVX10.85-0.07
-0.64%
Columbia Real Estate Equity Inst2